Galitzer Hillel
Galitzer Hillel, COO, reported a transaction classified as grant at Entera Bio Ltd. involving 72993.000000 shares for an estimated $0.00. Reported holdings after the transaction were 163566.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- May 07, 2026
- Filing date
- May 08, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ENTX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001178913-26-002466 Ordinary Shares, par value NIS 0.0000769 per share
- Transaction date
- May 07, 2026 Filed May 08, 2026, 08:29 PM · 1d delay
- Shares
- 72,993 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 163,566 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - grant_or_award-22 points
transaction_code = A
Grant or award transactions are scheduled compensation, not discretionary.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Operating Officer
- F1
Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on…
0 other transactions
0 recent txs